Trial Profile
A retrospective study to compare oxaliplatin + S1 and sorafenib in advanced hepatocellular carcinoma patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin; Sorafenib
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Sep 2015 New trial record